Merck & Co. Inc. buy Citigroup Inc.
Start price
28.01.25
/
50%
€93.60
Target price
28.01.26
€119.86
Performance (%)
-4.91%
End price
29.01.26
€89.00
Summary
This prediction ended on 29.01.26 with a price of €89.00. With a performance of -4.91%, the BUY prediction by Citigroup_Inc_ finished with a loss. Dividends of €0.81 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -2.458% | -2.458% | 59.169% |
| iShares Core DAX® | 3,15 % | 1,50 % | 9,13 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % | 28,64 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % | 53,03 % |
| iShares S&P 500 | 4,58 % | 1,92 % | 23,97 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Citigroup Inc. from $130.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€86.00
05.02.25
05.02.25
€110.32
05.02.26
05.02.26
17.91%
06.02.26
06.02.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€96.70
25.10.24
25.10.24
€120.32
25.10.25
25.10.25
-21.92%
26.10.25
26.10.25